Organometallics
Article
1
BPh4), 6.86 (t, 3JHH = 7.3 Hz, 8H; BPh4), 6.71 (t, 3JHH = 7.3 Hz, 4H;
BPh4), 1.88 (m, 8H), 1.63 (m, 8H), 1.68 (m, 8H), 1.43 (m, 16H),
1.00 (t, 3JHH = 7.2 Hz, 24H). 13C{1H} NMR (125 MHz, THF-d8, 298
importantly, no Rh−H unit is observed. H NMR data are broad
THF-d8, 298 K): δ = 53.1 (d, JRhP = 122 Hz). 11B{1H} NMR (161
1
1
MHz, THF-d8, 298 K): δ 19 (this shift is dependent on the amount of
K[HBEt3] addedsee Figure S31). Compound [6]7− was not
isolated, and thus, an elemental analysis was not performed.
K): δ 165.1 (q, JBC = 50.9 Hz; BPh4), 137.1 (BPh4), 125.5 (BPh4),
121.6 (BPh4), 33.2 (m), 26.6 (m), 20.3, 16.6. 31P{1H} NMR (203
1
MHz, THF-d8, 298 K): δ 53.7 (d, JRhP = 125.5 Hz). 11B{1H} NMR
[RhI(P2BCy4-μ-B−H−B)(P2BCy4)] (7; C124H233B8P4Rh, MW = 2037.5
g/mol). In the glovebox, [3]BPh4 (41 mg, 0.017 mmol, 1 equiv) was
placed in a 20 mL scintillation vial equipped with a stir bar.
Approximately 4 mL of THF was added, and [Rh(dnppe)2(H)] (5)
(11 mg, 0.017 mmol, 1 equiv) was added dropwise at room
temperaturethe reaction mixture was stirred for 30 min. The
resulting yellow solution was filtered through Celite, and volatiles
were removed in vacuo. Extraction of the residue into hexanes (to
remove [Rh(dnppe)2]BPh4 ([2]+)) and removal of solvent in vacuo
gave 7 as an orange oil (32 mg, 90%). 1H NMR (500 MHz, C6D6, 298
K): δ 2.30−1.10 (multiple broad overlapping C(sp3)−H resonances).
1H NMR (500 MHz, THF-d8, 243 K): δ 2.30−1.10 (multiple broad
(161 MHz, THF-d8, 298 K): δ −6.54 (BPh4). Anal. Calcd for
C52H84BP4Rh (946.5): C, 65.96; H, 8.94. Found: C, 66.17; H, 9.01.
{[RhI(P2BCy4)2]BPh4} ([3]BPh4; C148H252B9P4Rh, MW = 2355.7 g/
mol). In the glovebox, {[Rh(tape)2]BPh4} ([1]BPh4) (20 mg, 0.02
mmol, 1 equiv), and HBCy2 (31 mg, 0.17 mmol, 8 equivs) were
combined in a 20 mL scintillation vial equipped with a stir bar.
Approximately 4 mL of THF was added, and the solution was stirred
for 30 min at room temperature. The resulting yellow solution was
filtered through Celite, and the solvent was removed in vacuo to give
[3]BPh4 as a yellow foam (46 mg, 90%). 1H NMR (500 MHz, THF-
d8, 298 K): δ 7.29 (br, 8H; BPh4), 6.86 (t, 3JHH = 7.3 Hz, 8H; BPh4),
6.71 (t, 3JHH = 7.3 Hz, 4H; BPh4), 1.95 (m, 8H; P−CH2CH2 linker),
1.80−1.00 (multiple overlapping C(sp3)−H resonances). 13C{1H}
NMR (125 MHz, THF-d8, 298 K): δ 165.1 (q, 1JBC = 50.9 Hz; BPh4),
137.1 (BPh4), 125.5 (BPh4), 121.6 (BPh4), 36.5 (m), 33.5 (m), 28.8,
28.2, 27.9, 27.7, 27.6, 21.3. 31P{1H} NMR (203 MHz, THF-d8, 298
K): δ 54.1 (d, 1JRhP = 125.1 Hz). 11B{1H} NMR (161 MHz, THF-d8,
298 K): δ +83 (Δ1/2 = 2200 Hz), −6.54 (BPh4). Anal. Calcd for
C148H252B9P4Rh (2355.7): C, 75.46; H, 10.78. Best found: C, 74.00;
H, 10.79. These results are outside the range viewed as establishing
analytical purity but are provided to illustrate the best values obtained
to date. Clean NMR data indicate >95% purity.
overlapping C(sp3)−H resonances), 0.52 (m), 0.46 (m), 0.30 (m),
0.14 (m). 13C{1H} NMR (125 MHz, THF-d8, 298 K): δ 36.4 (v br),
35.3 (br), 29.7 (br), 28.1 (v br). 31P{1H} NMR (203 MHz, THF-d8,
298 K): δ 51.4 (v br). 31P{1H} NMR (203 MHz, THF-d8, 253 K): δ
53.3 (dt, 1JRh,P = 129 Hz, 2JPP = 30 Hz), 50.9 (dt, 1JRhP = 125 Hz, 2JPP
= 30 Hz). 11B{1H} NMR (161 MHz, THF-d8, 298 K): δ +94−58 (v
br); see Figure S45. 11B{1H} NMR (161 MHz, THF-d8, 193 K): no
signal.
Generation of a Model Compound, [Rh(dnppe)]2[HB(Cy)2(nOct)]
(8; C48H104BP4Rh, MW = 919 g/mol). In the glovebox,
n
[RhI(dnppe)2H] (5) (7 mg, 0.01 mmol, 1 equiv) and BCy2 Oct (7
[RhI(P2BCy4(nBu)4)2]7− ([4]7−). In the glovebox, [3]BPh4 (15 mg,
0.006 mmol, 1 equiv) was dissolved in ca. 500 μL of THF-d8 and the
mixture was transferred to a J. Young NMR tube. Subsequently, n-
BuLi (1.6 M in hexanes) (32 μL, 0.048 mmol, 8 equiv) was added and
the tube was shaken. The NMR tube was removed from the glovebox
and immediately analyzed by NMR spectroscopy. Efforts to isolate
[4]7− were not met with success due to poor solubility. By 31P NMR
mg, 0.024 mmol, 2 equiv) were combined in 500 μL of THF-d8. The
mixture was transferred to a J. Young NMR tube, removed from the
glovebox, and immediately analyzed by NMR spectroscopy, indicating
a 0.3:1 [RhI(dnppe)2H]:[RhI(dnppe)2]+ ratio. For the isolation of 8,
solvent was removed in vacuo and the resulting residue was washed
n
with hexanes (to remove unreacted 5 and BCy2 Oct), giving a yellow
n
1
spectroscopy, the conversion of [3]+ was >99%. H NMR data are
solid (9 mg, 88%). N.B.: despite there being 2 equiv of BCy2 Oct in
n
this reaction, the terminal borohydride [HBCy2 Oct]− and not the μ-
0.20 and −0.20 ppm are consistent with alkyl groups adjacent a four-
coordinate borate: 0.15 ppm (m, 16H; CH2), 0 (m, 8H; CH), −0.06
(m, 16H; CH2), −0.14 (m, 8H; CH). Importantly, no Rh−H unit is
observed. 31P{1H} NMR (203 MHz, THF-d8, 298 K): δ 46.1 (d, 1JRh,P
= 121 Hz). 11B{1H} NMR (161 MHz, THF-d8, 298 K): δ −16.3
H−B−H bridged borohydride counteranion was observed in the
isolated product. However, an analysis of the reaction mixture (prior
n
1
to isolation and removal of BCy2 Oct) revealed different H and 11B
NMR spectra, suggesting rapid exchange between terminal and
MHz, THF-d8, 298 K): δ 2.03 (m, 8H), 1.91 (m, 8H; P−CH2CH2
linker), 1.73 (m, 10H, obstructed by THF-d8), 1.63 (m, 10H), 1.51
n
([BCy2 BunPrP]−). Compound [4]7− was not isolated, and thus, an
elemental analysis was not performed.
3
[RhI(dnppe)2(H)] (5; C28H65P4Rh, MW = 628.6 g/mol). In the
glovebox, [2]BPh4 (20 mg, 0.02 mmol, 1 equiv) was placed in a 20
mL scintillation vial equipped with a stir bar. Approximately 4 mL of
THF was added, and n-BuLi (1.6 M in hexanes) (13 μL, 0.02 mmol, 1
equiv) was added at room temperaturethe reaction mixture was
stirred for 30 min. The resulting yellow solution was filtered through
Celite, and volatiles were removed in vacuo. Extraction of the residue
into hexanes and removal of the solvent in vacuo gave 5 as an orange
powder (11 mg, 82%). 1H NMR (500 MHz, THF-d8, 298 K): δ 1.50
(m, 16H), 1.40 (m, 16H), 1.39 (m, 8H; P−CH2CH2 linker), 0.95 (t,
3JHH = 7.1 Hz, 24H), − 12.2 (dq, 1JRhH = 11.8 Hz, 3JHP = 13.7 Hz, 1H;
Rh−H). 13C{1H} NMR (125 MHz, THF-d8, 298 K): δ 38.9 (m), 31.1
(m), 19.6, 16.5. 31P{1H} NMR (203 MHz, THF-d8, 298 K): δ 48.3
(m, 16H), 1.28 (m, 10H), 1.23−1.08 (m, 10H), 1.03 (t, JH,H = 7.3
3
Hz, 24H), 0.88 (t, JH,H = 7.2 Hz, 3H), 0.14 (m, 2H), 0.02 (m, 2H),
BH not observed. 31P{1H} NMR (203 MHz, THF-d8, 298 K): δ 54.0
(d, 1JRh,P = 125.3 Hz). 11B{1H} NMR (161 MHz, THF-d8, 298 K): δ
−4.6.20
Hydride Transfer from 7 to [BNAcP]PF6. In the glovebox,
[RhI(P2BCy4−H)(P2BCy4)] (7) (6 mg, 0.003 mmol, 1 equiv) and
[BNAcP]PF6 (1 mg, 0.003 mmol, 1 equiv) were combined in 500 μL
of THF-d8. The mixture was transferred to a J. Young NMR tube,
removed from the glovebox, and immediately analyzed by NMR
spectroscopy, which evidenced formation of 1,4-BNAcPH in 65%
1
(d, JRh,P = 139.9 Hz). FT-IR (ATR, cm−1): 1875 (Rh−H). Anal.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge at
■
sı
Calcd for C28H65P4Rh (628.6): C, 53.50; H, 10.42. Found: C, 53.59;
H, 11.18.
[RhI(P2BCy4(μ-HBEt3)4)2]7− ([6]7−). In the glovebox, [3]BPh4 (15
mg, 0.006 mmol, 1 equiv) was dissolved in ca. 500 μL of THF-d8 and
the mixture was transferred to a J. Young NMR tube. Subsequently,
K[HBEt3] (1 M in THF) (51 μL, 0.051 mmol, 8 equiv) was added
and the tube was shaken, giving a fluffy white solid and a yellow
solution. The NMR tube was removed from the glovebox and
immediately analyzed by NMR spectroscopy. Efforts to isolate [6]7−
were not met with success due to poor solubility. By 31P NMR
spectroscopy, the conversion of [3]+ was >99%. N.B.: the structure of
[6]7− is drawn to illustrate proposed interactions only. Most
1H, 13C{1H}, 31P{1H}, and 11B NMR spectra for all
complexes, crystallographic data, and computational
XYZ coordinates for DFT calculations (XYZ)
Accession Codes
tallographic data for this paper. These data can be obtained
2455
Organometallics 2021, 40, 2450−2457